ANSWERS: 1
-
Imitrex (sumatriptan succinate) is a migraine relief medicine developed by GlaxoSmithKline (GSK). It is taken orally or through the nasal cavities. The Imitrex patent expired in February 2009, after which, generic alternatives became available.
Source:
Copyright 2023, Wired Ivy, LLC